Diabetes Mellitus, Non-Insulin-Dependent
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A heterozygous protein-truncating RFX6 variant in a family with childhood-onset, pregnancy-associated and adult-onset diabetes.
|
31001871 |
2019 |
Ectopic gastric tissue
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In the embryonic intestine, the constitutive lack of Rfx6 leads to gastric heterotopia, suggesting a role in the maintenance of intestinal identity.
|
31668390 |
2019 |
Congenital Abnormality
|
0.010 |
Biomarker
|
group |
BEFREE |
Because of this, we propose that MFS/MRS is a symptom continuum or an RFX6 malformation complex.
|
25421130 |
2014 |
Agenesis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The phenotype of neonatal diabetes with intestinal atresia and biliary agenesis clearly pointed to RFX6 as the causative gene; indeed, whole exome sequencing revealed a novel homozygous RFX6 mutation c.779A>C; p.Lys260Thr (K260T).
|
23914949 |
2014 |
Intestinal Atresia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The phenotype of neonatal diabetes with intestinal atresia and biliary agenesis clearly pointed to RFX6 as the causative gene; indeed, whole exome sequencing revealed a novel homozygous RFX6 mutation c.779A>C; p.Lys260Thr (K260T).
|
23914949 |
2014 |
Tumor Progression
|
0.010 |
AlteredExpression
|
phenotype |
BEFREE |
Clinical data indicate that RFX6 upregulation in human prostate cancers correlates with tumor progression, metastasis and risk of biochemical relapse.
|
24390282 |
2014 |
Deformity
|
0.010 |
Biomarker
|
group |
BEFREE |
Because of this, we propose that MFS/MRS is a symptom continuum or an RFX6 malformation complex.
|
25421130 |
2014 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Suppression of RFX6 diminishes prostate cancer cell proliferation, migration and invasion.
|
24390282 |
2014 |
Benign Prostatic Hyperplasia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Two SNPs, rs12621278 in ITGA6 at 2q31 (OR = 0.82, P = 0.05) and rs339331 in RFX6 at 6q22 (OR = 1.22, P = 0.04) were significantly associated with BPH.
|
23620269 |
2013 |
Trichohepatoenteric Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In addition we review the clinical and molecular features of all RFX6 mutated cases to better characterize the syndrome.
|
21965172 |
2011 |
Maturity onset diabetes mellitus in young
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Clinical analysis of 36 individuals suggested that RFX6 mutation-induced MODY is characterized by low penetrance and relatively late onset.
|
31001871 |
2019 |
Maturity onset diabetes mellitus in young
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Our study demonstrates that heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance.Maturity-onset diabetes of the young (MODY) is the most common subtype of familial diabetes.Here, Patel et al. use targeted DNA sequencing of MODY patients and large-scale publically available data to show that RFX6 heterozygous protein truncating variants cause reduced penetrance MODY.
|
29026101 |
2017 |
Diabetes
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
We identified a previously reported p.Arg377Ter variant of RFX6 in a three-generation family with diabetes.
|
31001871 |
2019 |
Diabetes Mellitus
|
0.070 |
GeneticVariation
|
group |
BEFREE |
We identified a previously reported p.Arg377Ter variant of RFX6 in a three-generation family with diabetes.
|
31001871 |
2019 |
Diabetes
|
0.070 |
Biomarker
|
disease |
BEFREE |
RFX6 heterozygotes have reduced penetrance of diabetes compared to common HNF1A and HNF4A-MODY mutations (27, 70 and 55% at 25 years of age, respectively).
|
29026101 |
2017 |
Diabetes Mellitus
|
0.070 |
Biomarker
|
group |
BEFREE |
RFX6 heterozygotes have reduced penetrance of diabetes compared to common HNF1A and HNF4A-MODY mutations (27, 70 and 55% at 25 years of age, respectively).
|
29026101 |
2017 |
Diabetes
|
0.070 |
Biomarker
|
disease |
BEFREE |
However, the genetic mutation in (regulatory factor X on chromosome 6) RFX6 was only detected in babies who had diabetes, making it different from the previously known mutations for the disease.
|
26761945 |
2016 |
Diabetes
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
Two novel RFX6 variants in siblings with Mitchell-Riley syndrome with later diabetes onset and heterotopic gastric mucosa.
|
27523286 |
2016 |
Diabetes Mellitus
|
0.070 |
Biomarker
|
group |
BEFREE |
However, the genetic mutation in (regulatory factor X on chromosome 6) RFX6 was only detected in babies who had diabetes, making it different from the previously known mutations for the disease.
|
26761945 |
2016 |
Diabetes Mellitus
|
0.070 |
GeneticVariation
|
group |
BEFREE |
Two novel RFX6 variants in siblings with Mitchell-Riley syndrome with later diabetes onset and heterotopic gastric mucosa.
|
27523286 |
2016 |
Diabetes
|
0.070 |
AlteredExpression
|
disease |
BEFREE |
The later onset of diabetes in these patients may be due to incomplete inactivation of RFX6.
|
26264437 |
2015 |
Diabetes
|
0.070 |
GeneticVariation
|
disease |
BEFREE |
Therapeutic implications of novel mutations of the RFX6 gene associated with early-onset diabetes.
|
25048417 |
2015 |
Diabetes Mellitus
|
0.070 |
AlteredExpression
|
group |
BEFREE |
The later onset of diabetes in these patients may be due to incomplete inactivation of RFX6.
|
26264437 |
2015 |
Diabetes Mellitus
|
0.070 |
GeneticVariation
|
group |
BEFREE |
Therapeutic implications of novel mutations of the RFX6 gene associated with early-onset diabetes.
|
25048417 |
2015 |
Diabetes
|
0.070 |
Biomarker
|
disease |
BEFREE |
Rfx6 could prove useful in efforts to generate beta-cells for patients with diabetes.
|
20148032 |
2010 |